Drug –Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review
ConclusionsDOACs and DAAs are under-investigated for DDI risk. Real-world studies are needed to assess the clinical relevance of the pharmacokinetic interactions with dabigatran and describe the actual spectrum of possible DDIs between DAAs and other DOACs.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Bleeding | Conferences | Databases & Libraries | Drugs & Pharmacology | Hepatitis | Hepatitis C | Pradaxa | Study | Websites